Potassium Chloride
(WCUXLLCKKVVCTQ-UHFFFAOYSA-M)
Structure
- SMILES
- [Cl-].[K+]
- Type(s)
- Approved; Withdrawn
- ATC code(s)
- A12BA01; A12BA51; B05XA01
- Molecular Formula:
- ClK
- Molecular Weight:
- 74.551
- Log P:
- -2.9960
- Hydrogen Bond Acceptor:
- 0
- Hydrogen Bond Donor:
- 0
- TPSA:
- 0
- CAS Number(s):
- 7447-40-7; 14336-88-0
Synonym(s)
1.
Potassium Chloride
2.
Slow-K
3.
Chloride, Potassium
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Medication Error | FAERS: 42 Canada Vigilance: 20 | Canada Vigilance US FAERS | |
| 2 | Medication residue present | FAERS: 36 | US FAERS | |
| 3 | Cardiac Arrest | FAERS: 29 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 4 | Medication residue | FAERS: 28 | US FAERS | |
| 5 | Drug ineffective | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 6 | Vomiting | FAERS: 22 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 7 | Overdose | FAERS: 21 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 8 | Drug dispensing error | FAERS: 17 | US FAERS | |
| 9 | Blood potassium increased | FAERS: 16 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 10 | Blood potassium decreased | FAERS: 15 | US FAERS | |
| 11 | Suicide attempt | FAERS: 13 | US FAERS | |
| 12 | Nausea | FAERS: 10 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 13 | Pharmaceutical product complaint | FAERS: 10 | US FAERS | |
| 14 | Product physical issue | FAERS: 10 | US FAERS | |
| 15 | Product residue present | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 16 | Abdominal discomfort | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 17 | Completed Suicide | FAERS: 9 | US FAERS | |
| 18 | Drug administration error | FAERS: 9 | US FAERS | |
| 19 | Wrong drug administered | FAERS: 9 | US FAERS | |
| 20 | Bradycardia | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | Circumstance or information capable of leading to medication error | FAERS: 8 | US FAERS | |
| 22 | Gastric Lavage | FAERS: 8 | US FAERS | |
| 23 | Incorrect dose administered | FAERS: 8 | US FAERS | |
| 24 | Product label confusion | FAERS: 8 | US FAERS | |
| 25 | Toxicity to various agents | FAERS: 8 | US FAERS | |
| 26 | Wrong technique in product usage process | FAERS: 8 | US FAERS | |
| 27 | Choking | FAERS: 7 | US FAERS | |
| 28 | Intercepted drug dispensing error | FAERS: 7 | US FAERS | |
| 29 | Pain | FAERS: 7 Canada Vigilance: 2 | 21353389 | CTD Canada Vigilance US FAERS |
| 30 | Swelling | FAERS: 7 | US FAERS | |
| 31 | Throat irritation | FAERS: 7 | US FAERS | |
| 32 | Abdominal Pain | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 33 | Feeling abnormal | FAERS: 6 | US FAERS | |
| 34 | Malaise | FAERS: 6 | US FAERS | |
| 35 | Pallor | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 36 | Product solubility abnormal | FAERS: 6 | US FAERS | |
| 37 | Product use complaint | FAERS: 6 | US FAERS | |
| 38 | Tachycardia | FAERS: 6 | US FAERS | |
| 39 | Dyspepsia | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 40 | Electrocardiogram T wave peaked | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 41 | Flatulence | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 42 | Hypersensitivity | FAERS: 5 | US FAERS | |
| 43 | Hypotension | FAERS: 5 Canada Vigilance: 3 | 6465596 | CTD Canada Vigilance US FAERS |
| 44 | Product label issue | FAERS: 5 | US FAERS | |
| 45 | Product packaging issue | FAERS: 5 | US FAERS | |
| 46 | Product quality issue | FAERS: 5 | US FAERS | |
| 47 | Respiratory Failure | FAERS: 5 | US FAERS | |
| 48 | Respiratory arrest | FAERS: 5 | US FAERS | |
| 49 | Syncope | FAERS: 5 | US FAERS | |
| 50 | Wrong technique in drug usage process | FAERS: 5 | US FAERS | |
| 51 | Accidental overdose | FAERS: 4 | US FAERS | |
| 52 | Dizziness | FAERS: 4 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 53 | Electrocardiogram abnormal | FAERS: 4 | US FAERS | |
| 54 | Extravasation | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 55 | Foreign body in respiratory tract | FAERS: 4 | US FAERS | |
| 56 | Incorrect route of drug administration | FAERS: 4 | US FAERS | |
| 57 | Oropharyngeal pain | FAERS: 4 | US FAERS | |
| 58 | Product packaging confusion | FAERS: 4 | US FAERS | |
| 59 | Product physical consistency issue | FAERS: 4 | US FAERS | |
| 60 | Product size issue | FAERS: 4 | US FAERS | |
| 61 | Product substitution issue | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 62 | Urticaria | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 63 | Chest Pain | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 64 | Deafness | FAERS: 3 | US FAERS | |
| 65 | Diverticulitis | FAERS: 3 | US FAERS | |
| 66 | Drug prescribing error | FAERS: 3 | US FAERS | |
| 67 | Dysgeusia | FAERS: 3 | US FAERS | |
| 68 | Infusion site pain | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 69 | Intentional product misuse | FAERS: 3 | US FAERS | |
| 70 | Palpitations | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 71 | Product formulation issue | FAERS: 3 | US FAERS | |
| 72 | Pruritus | FAERS: 3 | US FAERS | |
| 73 | Retching | FAERS: 3 | US FAERS | |
| 74 | Skin necrosis | FAERS: 3 | US FAERS | |
| 75 | Accidental exposure to product | FAERS: 2 | US FAERS | |
| 76 | Accidental exposure | FAERS: 2 | US FAERS | |
| 77 | Angina Pectoris | FAERS: 2 | US FAERS | |
| 78 | Arthritis | FAERS: 2 | US FAERS | |
| 79 | Asthenia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 80 | Blepharospasm | FAERS: 2 | US FAERS | |
| 81 | Blood glucose increased | FAERS: 2 | US FAERS | |
| 82 | Bronchitis | FAERS: 2 | US FAERS | |
| 83 | Chromaturia | FAERS: 2 | US FAERS | |
| 84 | Cyanosis | FAERS: 2 | US FAERS | |
| 85 | Disease Progression | FAERS: 2 | US FAERS | |
| 86 | Erythema | FAERS: 2 | 3698061 | CTD US FAERS |
| 87 | Fatigue | FAERS: 2 | 3769383 | CTD US FAERS |
| 88 | Gastrectomy | FAERS: 2 | US FAERS | |
| 89 | Impaired gastric emptying | FAERS: 2 | US FAERS | |
| 90 | Injection site pain | FAERS: 2 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 91 | Intubation | FAERS: 2 | US FAERS | |
| 92 | Myalgia | FAERS: 2 | US FAERS | |
| 93 | Mydriasis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 94 | Pneumonia | FAERS: 2 | US FAERS | |
| 95 | Poor quality drug administered | FAERS: 2 | US FAERS | |
| 96 | Product barcode issue | FAERS: 2 | US FAERS | |
| 97 | Product coating issue | FAERS: 2 | US FAERS | |
| 98 | Product taste abnormal | FAERS: 2 | US FAERS | |
| 99 | Pulmonary Embolism | FAERS: 2 | US FAERS | |
| 100 | Sepsis | FAERS: 2 | US FAERS | |
| 101 | Shock | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 102 | Somnolence | FAERS: 2 | US FAERS | |
| 103 | Tooth Loss | FAERS: 2 | US FAERS | |
| 104 | Transcription medication error | FAERS: 2 | US FAERS | |
| 105 | Unevaluable event | FAERS: 2 | US FAERS | |
| 106 | Venous Thrombosis | FAERS: 2 | US FAERS | |
| 107 | Ventricular Fibrillation | FAERS: 2 | US FAERS | |
| 108 | Weight decreased | FAERS: 2 | US FAERS | |
| 109 | nervous system disorder | FAERS: 2 | US FAERS | |
| 110 | Abortion induced complicated | FAERS: 1 | US FAERS | |
| 111 | Acidosis | FAERS: 1 | 3769383 | CTD US FAERS |
| 112 | Alkalosis | FAERS: 1 | US FAERS | |
| 113 | Amnesia | FAERS: 1 | US FAERS | |
| 114 | Anaphylactic shock | FAERS: 1 | US FAERS | |
| 115 | Anxiety | FAERS: 1 | US FAERS | |
| 116 | Aplasia Cutis Congenita | FAERS: 1 | US FAERS | |
| 117 | Arterial Injury | FAERS: 1 | US FAERS | |
| 118 | Arteriosclerosis | FAERS: 1 | US FAERS | |
| 119 | Arthralgia | FAERS: 1 | US FAERS | |
| 120 | Asthma | FAERS: 1 | US FAERS | |
| 121 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 122 | Bedridden | FAERS: 1 | US FAERS | |
| 123 | Blindness | FAERS: 1 | US FAERS | |
| 124 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 125 | Blood potassium abnormal | FAERS: 1 | US FAERS | |
| 126 | Blood sodium decreased | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 127 | Blood urea increased | FAERS: 1 | US FAERS | |
| 128 | Brain Death | FAERS: 1 | US FAERS | |
| 129 | Bronchopulmonary Aspergillosis | FAERS: 1 | US FAERS | |
| 130 | Burning sensation | FAERS: 1 | US FAERS | |
| 131 | Carbon dioxide increased | FAERS: 1 | US FAERS | |
| 132 | Cardiac Flutter | FAERS: 1 | US FAERS | |
| 133 | Catheter related complication | FAERS: 1 | US FAERS | |
| 134 | Cellulitis | FAERS: 1 | US FAERS | |
| 135 | Cerebral Infarction | FAERS: 1 | US FAERS | |
| 136 | Cerebrovascular accident | FAERS: 1 | US FAERS | |
| 137 | Chemical burn of skin | FAERS: 1 | US FAERS | |
| 138 | Choking sensation | FAERS: 1 | US FAERS | |
| 139 | Colitis | FAERS: 1 | US FAERS | |
| 140 | Coronary Artery Disease | FAERS: 1 | US FAERS | |
| 141 | Dehydration | FAERS: 1 | US FAERS | |
| 142 | Delirium | FAERS: 1 | US FAERS | |
| 143 | Depressed mood | FAERS: 1 | US FAERS | |
| 144 | Device malfunction | FAERS: 1 | US FAERS | |
| 145 | Drug Dependence | FAERS: 1 | US FAERS | |
| 146 | Drug effect incomplete | FAERS: 1 | US FAERS | |
| 147 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 148 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 149 | Dyschezia | FAERS: 1 | US FAERS | |
| 150 | Electrocardiogram change | FAERS: 1 | US FAERS | |
| 151 | Embolism | FAERS: 1 | US FAERS | |
| 152 | Emotional distress | FAERS: 1 | US FAERS | |
| 153 | Epigastric discomfort | FAERS: 1 | US FAERS | |
| 154 | Excoriation | FAERS: 1 | US FAERS | |
| 155 | Foreign body trauma | FAERS: 1 | US FAERS | |
| 156 | Gastric ulcer | FAERS: 1 | US FAERS | |
| 157 | Gastrointestinal sounds abnormal | FAERS: 1 | US FAERS | |
| 158 | General physical health deterioration | FAERS: 1 | US FAERS | |
| 159 | Gluten sensitivity | FAERS: 1 | US FAERS | |
| 160 | Headache | FAERS: 1 | US FAERS | |
| 161 | Hyperventilation | FAERS: 1 | US FAERS | |
| 162 | Hypoxia | FAERS: 1 | US FAERS | |
| 163 | Incorrect drug administration rate | FAERS: 1 | US FAERS | |
| 164 | Infarction | FAERS: 1 | US FAERS | |
| 165 | Influenza | FAERS: 1 | US FAERS | |
| 166 | Infusion site vesicles | FAERS: 1 | US FAERS | |
| 167 | Injection site irritation | FAERS: 1 | US FAERS | |
| 168 | Intentional drug misuse | FAERS: 1 | US FAERS | |
| 169 | Intercepted drug administration error | FAERS: 1 | US FAERS | |
| 170 | Intercepted drug prescribing error | FAERS: 1 | US FAERS | |
| 171 | Intercepted medication error | FAERS: 1 | US FAERS | |
| 172 | Intercepted product storage error | FAERS: 1 | US FAERS | |
| 173 | Intestinal Obstruction | FAERS: 1 | US FAERS | |
| 174 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 175 | Joint Range of Motion Decreased | FAERS: 1 | US FAERS | |
| 176 | Joint swelling | FAERS: 1 | US FAERS | |
| 177 | Limb discomfort | FAERS: 1 | US FAERS | |
| 178 | Lip swelling | FAERS: 1 | US FAERS | |
| 179 | Malabsorption | FAERS: 1 | US FAERS | |
| 180 | Memory impairment | FAERS: 1 | US FAERS | |
| 181 | Morbid thoughts | FAERS: 1 | US FAERS | |
| 182 | Musculoskeletal Pain | FAERS: 1 | US FAERS | |
| 183 | Musculoskeletal stiffness | FAERS: 1 | US FAERS | |
| 184 | Myoglobin blood increased | FAERS: 1 | US FAERS | |
| 185 | Myoglobinuria | FAERS: 1 | US FAERS | |
| 186 | Nervousness | FAERS: 1 | US FAERS | |
| 187 | No adverse effect | FAERS: 1 | US FAERS | |
| 188 | No adverse event | FAERS: 1 | US FAERS | |
| 189 | Oral pain | FAERS: 1 | US FAERS | |
| 190 | Oropharyngeal discomfort | FAERS: 1 | US FAERS | |
| 191 | Oropharyngeal swelling | FAERS: 1 | US FAERS | |
| 192 | Osteomyelitis | FAERS: 1 | US FAERS | |
| 193 | Paraplegia | FAERS: 1 | US FAERS | |
| 194 | Peripheral swelling | FAERS: 1 | US FAERS | |
| 195 | Procedural complication | FAERS: 1 | US FAERS | |
| 196 | Product appearance confusion | FAERS: 1 | US FAERS | |
| 197 | Product difficult to swallow | FAERS: 1 | US FAERS | |
| 198 | Product dispensing error | FAERS: 1 | US FAERS | |
| 199 | Product label on wrong product | FAERS: 1 | US FAERS | |
| 200 | Product name confusion | FAERS: 1 | US FAERS | |
| 201 | Product outer packaging issue | FAERS: 1 | US FAERS | |
| 202 | Product preparation error | FAERS: 1 | US FAERS | |
| 203 | Reaction to drug excipients | FAERS: 1 | US FAERS | |
| 204 | Rebound effect | FAERS: 1 | US FAERS | |
| 205 | Restless Legs Syndrome | FAERS: 1 | US FAERS | |
| 206 | Scan adrenal gland abnormal | FAERS: 1 | US FAERS | |
| 207 | Sinus Tachycardia | FAERS: 1 | US FAERS | |
| 208 | Skin lesion | FAERS: 1 | US FAERS | |
| 209 | Skin nodule | FAERS: 1 | US FAERS | |
| 210 | Spondylitis | FAERS: 1 | US FAERS | |
| 211 | Stevens-Johnson Syndrome | FAERS: 1 | US FAERS | |
| 212 | Stool analysis abnormal | FAERS: 1 | US FAERS | |
| 213 | Sudden death | FAERS: 1 | US FAERS | |
| 214 | Therapeutic response unexpected with drug substitution | FAERS: 1 | US FAERS | |
| 215 | Therapy cessation | FAERS: 1 | US FAERS | |
| 216 | Therapy non-responder | FAERS: 1 | US FAERS | |
| 217 | Unresponsive to stimuli | FAERS: 1 | US FAERS | |
| 218 | Urinary tract infection | FAERS: 1 | US FAERS | |
| 219 | Ventricular arrhythmia | FAERS: 1 | US FAERS | |
| 220 | Wrong product stored | FAERS: 1 | US FAERS | |
| 221 | Agitation | Canada Vigilance: 1 | Canada Vigilance | |
| 222 | Anaphylactoid Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 223 | Confusion | 3769383 | CTD | |
| 224 | Edema | 3698061 | CTD | |
| 225 | Forced expiratory volume abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 226 | Heart failure | 3709557 | CTD | |
| 227 | Hyperkalemia | CTD | ||
| 228 | Hypokalemia | CTD | ||
| 229 | Hypoventilation | Canada Vigilance: 1 | Canada Vigilance | |
| 230 | Inflammation | Canada Vigilance: 1 | Canada Vigilance | |
| 231 | Injection Site Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 232 | Lethargy | 3769383 | CTD | |
| 233 | Memory Disorders | 561405 | CTD | |
| 234 | Phlebitis | Canada Vigilance: 2 | Canada Vigilance | |
| 235 | Product administration error | Canada Vigilance: 3 | Canada Vigilance | |
| 236 | Pulmonary congestion | Canada Vigilance: 1 | Canada Vigilance | |
| 237 | Respiratory Depression | Canada Vigilance: 1 | Canada Vigilance | |
| 238 | Seizures | 6405441 | CTD | |
| 239 | Spasm | 2444298 3742162 8680739 | CTD | |
| 240 | Tremor | Canada Vigilance: 2 | Canada Vigilance | |
| 241 | Urinary Incontinence | 3769383 | CTD | |
| 242 | Wrong product administered | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.